FDA Inspection 1020421 — Roche Molecular Systems, Inc.
The FDA completed an inspection of Roche Molecular Systems, Inc. on Jul 19, 2017 in Branchburg, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Branchburg, NJ (United States)